Noninvasive Cardiovascular Imaging in Rheumatoid Arthritis: Current Modalities and the Emerging Role of Magnetic Resonance and Positron Emission Tomography Imaging

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 5, 2012, Pages 676-688

  Furer, Victoria ^a   Fayad, Zahi A ^b   Mani, Venkatesh ^b   Calcagno, Claudia ^b   Farkouh, Michael E ^b   Greenberg, Jeffrey D ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cardiac computed tomography; Cardiovascular imaging; Inflammation; Magnetic resonance imaging; Plaque; Positron emission tomography; Rheumatoid arthritis; Ultrasonography; Vessel wall

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANKLE BRACHIAL INDEX; AORTA ATHEROSCLEROSIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; ECHOGRAPHY; ELECTRON BEAM TOMOGRAPHY; HEART PERFUSION; HEMODYNAMICS; HUMAN; MYOCARDIAL DISEASE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW;

ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MASS SCREENING; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY;

EID: 84859428996     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.08.007     Document Type: Article

References (129)

1. del Rincon I.D., Williams K., Stern M.P., Freeman G.L., Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 44(12):2737-2745.
2. Solomon D.H., Karlson E.W., Rimm E.B., Cannuscio C.C., Mandl L.A., Manson J.E., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107(9):1303-1307.
3. Peters M.J., Symmons D.P., McCarey D., Dijkmans B.A., Nicola P., Kvien T.K., et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010, 69(2):325-331.
4. Dessein P.H., Joffe B.I., Stanwix A.E. Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis. J Rheumatol 2003, 30(7):1403-1405.
5. Choi H.K., Seeger J.D. Lipid profiles among US elderly with untreated rheumatoid arthritis-the Third National Health and Nutrition Examination Survey. J Rheumatol 2005, 32(12):2311-2316.
6. van Halm V.P., Peters M.J., Voskuyl A.E., Boers M., Lems W.F., Visser M., et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 2009, 68(9):1395-1400.
7. Solomon D.H., Kremer J., Curtis J.R., Hochberg M.C., Reed G., Tsao P., et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 2010, 69(11):1920-1925.
8. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008, 121(10 Suppl 1):S21-S31.
9. Wallberg-Jonsson S., Johansson H., Ohman M.L., Rantapaa-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999, 26(12):2562-2571.
10. Jacobsson L.T., Turesson C., Hanson R.L., Pillemer S., Sievers M.L., Pettitt D.J., et al. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. Arthritis Rheum 2001, 44(5):1170-1176.
11. Del Rincon I., Williams K., Stern M.P., Freeman G.L., O'Leary D.H., Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003, 48(7):1833-1840.
12. Goodson N.J., Symmons D.P., Scott D.G., Bunn D., Lunt M., Silman A.J. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year follow up study of a primary care-based inception cohort. Arthritis Rheum 2005, 52(8):2293-2299.
13. Turesson C., McClelland R.L., Christianson T.J., Matteson E.L. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 2007, 66(1):70-75.
14. Gabriel S.E. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 2008, 121(10 Suppl 1):S9-S14.
15. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97(18):1837-1847.
16. Dessein P.H., Joffe B.I., Veller M.G., Stevens B.A., Tobias M., Reddi K., et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005, 32(3):435-442.
17. Ridker P.M., Buring J.E., Rifai N., Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007, 297(6):611-619.
18. Pasceri V., Yeh E.T. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999, 100(21):2124-2126.
19. Aubry M.C., Maradit-Kremers H., Reinalda M.S., Crowson C.S., Edwards W.D., Gabriel S.E. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007, 34(5):937-942.
20. Stamatelopoulos K.S., Kitas G.D., Papamichael C.M., Chryssohoou E., Kyrkou K., Georgiopoulos G., et al. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol 2009, 29(10):1702-1708.
21. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006, 47(Suppl 8):C13-C18.
22. Moreno P.R., Purushothaman K.R., Zias E., Sanz J., Fuster V. Neovascularization in human atherosclerosis. Curr Mol Med 2006, 6(5):457-477.
23. Rudd J.H., Hyafil F., Fayad Z.A. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol 2009, 29(7):1009-1016.
24. Jacobsson L.T., Turesson C., Gulfe A., Kapetanovic M.C., Petersson I.F., Saxne T., et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005, 32(7):1213-1218.
25. Dixon W.G., Watson K.D., Lunt M., Hyrich K.L., Silman A.J., Symmons D.P. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007, 56(9):2905-2912.
26. O'Leary D.H., Bots M.L. Imaging of atherosclerosis: carotid intima-media thickness. Eur Heart J 2010, 31(14):1682-1689.
27. Pignoli P., Tremoli E., Poli A., Oreste P., Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986, 74(6):1399-1406.
28. Stein J.H., Korcarz C.E., Hurst R.T., Lonn E., Kendall C.B., Mohler E.R., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008, 21(2):93-111. quiz 89-90.
29. Bots M.L., Baldassarre D., Simon A., de Groot E., O'Leary D.H., Riley W., et al. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?. Eur Heart J 2007, 28(4):398-406.
30. Urbina E.M., Srinivasan S.R., Tang R., Bond M.G., Kieltyka L., Berenson G.S. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). Am J Cardiol 2002, 90(9):953-958.
31. Zarins C.K., Giddens D.P., Bharadvaj B.K., Sottiurai V.S., Mabon R.F., Glagov S. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res 1983, 53(4):502-514.
32. Roman M.J., Naqvi T.Z., Gardin J.M., Gerhard-Herman M., Jaff M., Mohler E. American society of echocardiography report. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med 2006, 11(3):201-211.
33. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340(1):14-22.
34. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115(4):459-467.
35. Revkin J.H., Shear C.L., Pouleur H.G., Ryder S.W., Orloff D.G. Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future. Pharmacol Rev 2007, 59(1):40-53.
36. Tyrrell P.N., Beyene J., Feldman B.M., McCrindle B.W., Silverman E.D., Bradley T.J. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2010, 30(5):1014-1026.
37. van Sijl A.M., Peters M.J., Knol D.K., de Vet H.C., Gonzalez-Gay M.A., Smulders Y.M., et al. Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum 2011, 40(5):389-397.
38. Park Y.B., Ahn C.W., Choi H.K., Lee S.H., In B.H., Lee H.C., et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002, 46(7):1714-1719.
39. Grover S., Sinha R.P., Singh U., Tewari S., Aggarwal A., Misra R. Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol 2006, 33(2):244-247.
40. Kumeda Y., Inaba M., Goto H., Nagata M., Henmi Y., Furumitsu Y., et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002, 46(6):1489-1497.
41. Del Rincon I., O'Leary D.H., Freeman G.L., Escalante A. Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 2007, 195(2):354-360.
42. Roman M.J., Moeller E., Davis A., Paget S.A., Crow M.K., Lockshin M.D., et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006, 144(4):249-256.
43. Kobayashi H., Giles J.T., Polak J.F., Blumenthal R.S., Leffell M.S., Szklo M., et al. Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific. J Rheumatol 2010, 37(4):730-739.
44. Nagata-Sakurai M., Inaba M., Goto H., Kumeda Y., Furumitsu Y., Inui K., et al. Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 2003, 48(11):3061-3067.
45. Gonzalez-Juanatey C., Llorca J., Martin J., Gonzalez-Gay M.A. Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 2009, 38(5):366-371.
46. Evans M.R., Escalante A., Battafarano D.F., Freeman G.L., O'Leary D.H., Del Rincon I. Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis Rheum 2011, 63(5):1211-1220.
47. Finn A.V., Kolodgie F.D., Virmani R. Correlation between carotid intimal/medial thickness and atherosclerosis. A point of view from pathology. Arterioscler Thromb Vasc Biol 2010, 30(2):177-181.
48. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery. Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006, 47(6):1239-1312.
49. Newman A.B., Siscovick D.S., Manolio T.A., Polak J., Fried L.P., Borhani N.O., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993, 88(3):837-845.
50. Papamichael C.M., Lekakis J.P., Stamatelopoulos K.S., Papaioannou T.G., Alevizaki M.K., Cimponeriu A.T., et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 2000, 86(6):615-618.
51. Ogren M., Hedblad B., Isacsson S.O., Janzon L., Jungquist G., Lindell S.E. Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis. Lancet 1993, 342(8880):1138-1141.
52. Leng G.C., Fowkes F.G., Lee A.J., Dunbar J., Housley E., Ruckley C.V. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996, 313(7070):1440-1444.
53. van der Meer I.M., Bots M.L., Hofman A., del Sol A.I., van der Kuip D.A., Witteman J.C. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004, 109(9):1089-1094.
54. Murabito J.M., Evans J.C., Larson M.G., Nieto K., Levy D., Wilson P.W. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med 2003, 163(16):1939-1942.
55. Fowkes F.G., Murray G.D., Butcher I., Heald C.L., Lee R.J., Chambless L.E., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008, 300(2):197-208.
56. del Rincon I., Haas R.W., Pogosian S., Escalante A. Lower limb arterial incompressibility and obstruction in rheumatoid arthritis. Ann Rheum Dis 2005, 64(3):425-432.
57. Chung C.P., Giles J.T., Szklo M., Post W., Petri M.A., Blumenthal R., et al. Interleukin-6 levels are associated with elevated ankle brachial index in rheumatoid arthritis [Abstract]. Arthritis Rheum 2010, 62(Suppl 10):S950.
58. Ramirez C., Escalante A., Sahai M., Battafarano D., Pogosian S., Del Rincon I. Prediction of 10-year cardiovascular and all-cause mortality in rheumatoid arthritis using the ankle-brachial index [Abstract]. Arthritis Rheum 2010, 62(Suppl 10):S437.
59. Nicolai S.P., Kruidenier L.M., Rouwet E.V., Bartelink M.L., Prins M.H., Teijink J.A. Ankle brachial index measurement in primary care: are we doing it right?. Br J Gen Pract 2009, 59(563):422-427.
60. Budoff M.J., Achenbach S., Blumenthal R.S., Carr J.J., Goldin J.G., Greenland P., et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention. Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006, 114(16):1761-1791.
61. Greenland P., Bonow R.O., Brundage B.H., Budoff M.J., Eisenberg M.J., Grundy S.M., et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 2007, 115(3):402-426.
62. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull W., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995, 92(5):1355-1374.
63. Wexler L., Brundage B., Crouse J., Detrano R., Fuster V., Maddahi J., et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association Writing Group. Circulation 1996, 94(5):1175-1192.
64. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15(4):827-832.
65. Pletcher M.J., Tice J.A., Pignone M., Browner W.S. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 2004, 164(12):1285-1292.
66. Detrano R., Guerci A.D., Carr J.J., Bild D.E., Burke G., Folsom A.R., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008, 358(13):1336-1345.
67. Shaw L.J., Raggi P., Schisterman E., Berman D.S., Callister T.Q. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003, 228(3):826-833.
68. Budoff M.J., Shaw L.J., Liu S.T., Weinstein S.R., Mosler T.P., Tseng P.H., et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 2007, 49(18):1860-1870.
69. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003, 24(17):1601-1610.
70. Chung C.P., Oeser A., Raggi P., Gebretsadik T., Shintani A.K., Sokka T., et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 2005, 52(10):3045-3053.
71. Kao A.H., Wasko M.C., Krishnaswami S., Wagner J., Edmundowicz D., Shaw P., et al. C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis. Am J Cardiol 2008, 102(6):755-760.
72. Giles J.T., Szklo M., Post W., Petri M., Blumenthal R.S., Lam G., et al. Coronary arterial calcification in rheumatoid arthritis: comparison with the multi-ethnic study of atherosclerosis. Arthritis Res Ther 2009, 11(2):R36.
73. Wang S., Yiu K.H., Mok M.Y., Ooi G.C., Khong P.L., Mak K.F., et al. Prevalence and extent of calcification over aorta, coronary and carotid arteries in patients with rheumatoid arthritis. J Intern Med 2009, 266(5):445-452.
74. Chung C.P., Oeser A., Avalos I., Gebretsadik T., Shintani A., Raggi P., et al. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 2006, 8(6):R186.
75. Chung C.P., Oeser A., Solus J.F., Avalos I., Gebretsadik T., Shintani A., et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008, 196(2):756-763.
76. Rho Y.H., Chung C.P., Oeser A., Solus J., Asanuma Y., Sokka T., et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2009, 61(11):1580-1585.
77. Kao A.H., Krishnaswami S., Cunningham A., Edmundowicz D., Morel P.A., Kuller L.H., et al. Subclinical coronary artery calcification and relationship to disease duration in women with rheumatoid arthritis. J Rheumatol 2008, 35(1):61-69.
78. Giles J.T., Post W., Szklo M., Blumenthal R.S., Petri M., Gelber A., et al. Discordance in the association of carotid with coronary atherosclerosis in rheumatoid arthritis compared with controls [Abstract]. Arthritis Rheum 2009, 60(Suppl 10):S601.
79. Taylor A.J., Cerqueira M., Hodgson J.M., Mark D., Min J., O'Gara P., et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Comput Tomogr 2010, 4(6):407e1-433.
80. Kim K.P., Einstein A.J., Berrington de Gonzalez A. Coronary artery calcification screening: estimated radiation dose and cancer risk. Arch Intern Med 2009, 169(13):1188-1194.
81. Mettler F.A., Huda W., Yoshizumi T.T., Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008, 248(1):254-263.
82. Kaul P., Douglas P.S. Atherosclerosis imaging: prognostically useful or merely more of what we know?. Circ Cardiovasc Imaging 2009, 2(2):150-160.
83. Fayad Z.A. MR imaging for the noninvasive assessment of atherothrombotic plaques. Magn Reson Imaging Clin N Am 2003, 11(1):101-113.
84. Fayad Z.A., Fuster V., Fallon J.T., Jayasundera T., Worthley S.G., Helft G., et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000, 102(5):506-510.
85. Hatsukami T.S., Ross R., Polissar N.L., Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000, 102(9):959-964.
86. Botnar R.M., Stuber M., Kissinger K.V., Kim W.Y., Spuentrup E., Manning W.J. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 2000, 102(21):2582-2587.
87. Desai M.Y., Lai S., Barmet C., Weiss R.G., Stuber M. Reproducibility of 3D free-breathing magnetic resonance coronary vessel wall imaging. Eur Heart J 2005, 26(21):2320-2324.
88. Sanz J., Fayad Z.A. Imaging of atherosclerotic cardiovascular disease. Nature 2008, 451(7181):953-957.
89. Toussaint J.F., LaMuraglia G.M., Southern J.F., Fuster V., Kantor H.L. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996, 94(5):932-938.
90. Yuan C., Mitsumori L.M., Ferguson M.S., Polissar N.L., Echelard D., Ortiz G., et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001, 104(17):2051-2056.
91. Itskovich V.V., Samber D.D., Mani V., Aguinaldo J.G., Fallon J.T., Tang C.Y., et al. Quantification of human atherosclerotic plaques using spatially enhanced cluster analysis of multicontrast-weighted magnetic resonance images. Magn Reson Med 2004, 52(3):515-523.
92. Fuster V., Fayad Z.A., Moreno P.R., Poon M., Corti R., Badimon J.J. Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol 2005, 46(7):1209-1218.
93. Briley-Saebo K.C., Mulder W.J., Mani V., Hyafil F., Amirbekian V., Aguinaldo J.G., et al. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J Magn Reson Imaging 2007, 26(3):460-479.
94. Anderson R.W., Stomberg C., Hahm C.W., Mani V., Samber D.D., Itskovich V.V., et al. Automated classification of atherosclerotic plaque from magnetic resonance images using predictive models. Biosystems 2007, 90(2):456-466.
95. Cai J.M., Hatsukami T.S., Ferguson M.S., Small R., Polissar N.L., Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 2002, 106(11):1368-1373.
96. Underhill H.R., Yuan C., Terry J.G., Chen H., Espeland M.A., Hatsukami T.S., et al. Differences in carotid arterial morphology and composition between individuals with and without obstructive coronary artery disease: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2008, 10:31.
97. Corti R., Fayad Z.A., Fuster V., Worthley S.G., Helft G., Chesebro J., et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001, 104(3):249-252.
98. Corti R., Fuster V., Fayad Z.A., Worthley S.G., Helft G., Smith D., et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002, 106(23):2884-2887.
99. Calcagno C., Mani V., Ramachandran S., Fayad Z.A. Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis. Angiogenesis 2010, 13(2):87-99.
100. Fleiner M., Kummer M., Mirlacher M., Sauter G., Cathomas G., Krapf R., et al. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation 2004, 110(18):2843-2850.
101. Saam T., Yuan C., Chu B., Takaya N., Underhill H., Cai J., et al. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis 2007, 194(2):e34-e42.
102. Corti R., Fuster V., Fayad Z.A., Worthley S.G., Helft G., Chaplin W.F., et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 2005, 46(1):106-112.
103. Zhao X.Q., Yuan C., Hatsukami T.S., Frechette E.H., Kang X.J., Maravilla K.R., et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study. Arterioscler Thromb Vasc Biol 2001, 21(10):1623-1629.
104. Ruehm S.G., Corot C., Vogt P., Kolb S., Debatin J.F. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001, 103(3):415-422.
105. Morishige K., Kacher D.F., Libby P., Josephson L., Ganz P., Weissleder R., et al. High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis. Circulation 2010, 122(17):1707-1715.
106. Kooi M.E., Cappendijk V.C., Cleutjens K.B., Kessels A.G., Kitslaar P.J., Borgers M., et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003, 107(19):2453-2458.
107. Saraste A., Nekolla S., Schwaiger M. Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability. J Nucl Cardiol 2008, 15(1):105-117.
108. Hunold P., Schlosser T., Vogt F.M., Eggebrecht H., Schmermund A., Bruder O., et al. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol 2005, 184(5):1420-1426.
109. Panting J.R., Gatehouse P.D., Yang G.Z., Grothues F., Firmin D.N., Collins P., et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002, 346(25):1948-1953.
110. Bernhardt P., Levenson B., Albrecht A., Engels T., Strohm O. Detection of cardiac small vessel disease by adenosine-stress magnetic resonance. Int J Cardiol 2007, 121(3):261-266.
111. Kobayashi Y., Giles J.T., Hirano M., Yokoe I., Nakajima Y., Bathon J.M., et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther 2010, 12(5):R171.
112. Keenan N.G., Mason J.C., Maceira A., Assomull R., O'Hanlon R., Chan C., et al. Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance. Arthritis Rheum 2009, 60(11):3501-3509.
113. Schillaci O., Danieli R., Padovano F., Testa A., Simonetti G. Molecular imaging of atheroslerotic plaque with nuclear medicine techniques. Int J Mol Med 2008, 22(1):3-7.
114. Rudd J.H., Myers K.S., Bansilal S., Machac J., Rafique A., Farkouh M., et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007, 50(9):892-896.
115. Yun M., Yeh D., Araujo L.I., Jang S., Newberg A., Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 2001, 26(4):314-319.
116. Rudd J.H., Warburton E.A., Fryer T.D., Jones H.A., Clark J.C., Antoun N., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002, 105(23):2708-2711.
117. Davies M.J., Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984, 310(18):1137-1140.
118. Jander S., Sitzer M., Schumann R., Schroeter M., Siebler M., Steinmetz H., et al. Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke 1998, 29(8):1625-1630.
119. Ogawa M., Ishino S., Mukai T., Asano D., Teramoto N., Watabe H., et al. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 2004, 45(7):1245-1250.
120. Tawakol A., Migrino R.Q., Hoffmann U., Abbara S., Houser S., Gewirtz H., et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 2005, 12(3):294-301.
121. Zhang Z., Machac J., Helft G., Worthley S.G., Tang C., Zaman A.G., et al. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med 2006, 6:3.
122. Tawakol A., Migrino R.Q., Bashian G.G., Bedri S., Vermylen D., Cury R.C., et al. In Vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006, 48(9):1818-1824.
123. Rudd J.H., Myers K.S., Bansilal S., Machac J., Woodward M., Fuster V., et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging 2009, 2(2):107-115.
124. Yoo H.J., Kim S., Park M.S., Yang S.J., Kim T.N., Seo J.A., et al. Vascular inflammation stratified by C-reactive protein and low-density lipoprotein cholesterol levels: analysis with 18F-FDG PET. J Nucl Med 2011, 52(1):10-17.
125. Mehta N.N., Yu Y., Saboury B., Foroughi N., Krishnamoorthy P., Raper A., et al. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol 2011, 147(9):1031-1039.
126. Huang B., Law M.W., Khong P.L. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology 2009, 251(1):166-174.
127. Folsom A.R., Kronmal R.A., Detrano R.C., O'Leary D.H., Bild D.E., Bluemke D.A., et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008, 168(12):1333-1339.
128. Lester S.J., Eleid M.F., Khandheria B.K., Hurst R.T. Carotid intima-media thickness and coronary artery calcium score as indications of subclinical atherosclerosis. Mayo Clin Proc 2009, 84(3):229-233.
129. Silvera S.S., Aidi H.E., Rudd J.H., Mani V., Yang L., Farkouh M., et al. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. Artherosclerosis 2009, 207(1):139-143.